Original Publication Date: 1 January, 2015
Publication / Source: Biomarkers in Medicine
Authors: Pooja P Advani, Jennifer A Crozier & Edith A Perez
Breast cancer treatment is dependent on accurate pathologic diagnosis. HER2 testing is now universally recommended as part of evaluation of invasive breast cancer. HER2 testing is available via various slide and non-slide based assays, and interpretation of results continues to evolve.